AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (903.5 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease

Souvik Kara,1( ), Andrea Perrellib,c,j,1, Kiran Kumar Balid, Raffaella Mastrocolab,c, Arpita Kare,f, Bushra Khang, Luis Gandg, Arnab Nayakg, Christian Hartmannh, Wolfram S. Kunzi, Amir Samiia, Helmut Bertalanffya, Saverio Francesco Rettab,c( )
International Neuroscience Institute, Rudolf-Pichlmayr-Strasse 4, Hannover 30625, Germany
Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy
Department of Experimental Pain Research, Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim 68167, Germany
Department of Kidney, Liver and Metabolic Diseases, Children’s Hospital, Hannover Medical School, Hannover 30625, Germany
Ricarda-Huch-Street-10B, Hannover 30880, Germany
Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover 30625, Germany
Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover 30625, Germany
Institute of Experimental Epileptology and Cognition Research and Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, Bonn 53127, Germany
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA

1 These authors contributed equally to this study and shared first-name authorship.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 11 Issue 1,
January 2024
Pages 67-71
DOI: 10.1016/j.gendis.2023.02.045

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Kar S, Perrelli A, Bali KK, et al. Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease. Genes & Diseases, 2024, 11(1): 67-71. https://doi.org/10.1016/j.gendis.2023.02.045

716

Views

7

Downloads

6

Crossref

6

Web of Science

6

Scopus

0

CSCD
Received: 18 November 2022
Published: 03 April 2023
© 2023 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).